Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: The roles of cytokines and CD40

Brain Research

Volumn 807, Issue 1-2, 1998, Pages 110-117

  Suo, Zhiming ^a   Tan, Jun ^a   Placzek, Andon ^a   Crawford, Fiona ^a   Fang, Chunhong ^a   Mullan, Michael ^a  

^a ROSKAMP INSTITUTE   (United States)

Author keywords

amyloid (A ); Alzheimer's disease (AD); CD40; Cytokine; Interferon (IFN ); Interleukin 1 (IL 1 )

Indexed keywords

AMYLOID BETA PROTEIN; CD40 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA;

ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD VESSEL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MEDIATOR RELEASE; PATHOGENESIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIGENS, CD40; CELL LINE; CYTOKINES; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-1; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 0032487625     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00780-X     Document Type: Article

References (43)

1. Aisen P.S. Inflammation and Alzheimer disease. Mol. Chem. Neuropathol. 28:1996;83-88.
2. Altstiel L.D., Sperber K. Cytokines in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry. 15:1991;481-495.
3. Anthony D.C., Bolton S.J., Fearn S., Perry V.H. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain. 120:1997;435-444.
4. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202:1995;17-20.
5. Chen S., Frederickson R.C., Brunden K.R. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches. Neurobiol. Aging. 17:1996;781-787.
6. Cohen D.L., Hedera P., Premkumar D.R., Friedland R.P., Kalaria R.N. Amyloid-beta protein angiopathies masquerading as Alzheimer's disease? Ann. NY Acad. Sci. 826:1997;390-395.
7. Eikelenboom P., Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging. 17:1996;673-680.
8. Forloni G., Demicheli F., Giorgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Res. Mol. Brain Res. 16:1992;128-134.
9. Fukuo K., Nakahashi T., Nomura S., Hata S., Suhara T., Shimizu M., Tamatani M., Morimoto S., Kitamura Y., Ogihara T. Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis. Gerontology. 43(1):1997;35-42. Suppl.
10. Geng Y.J., Hellstrand K., Wennmalm A., Hansson G.K. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha. Cancer Res. 56:1996;866-874.
11. Geng Y.J., Henderson L.E., Levesque E.B., Muszynski M., Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17:1997;2200-2208.
12. Geng Y.J., Wu Q., Muszynski M., Hansson G.K., Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler. Thromb. Vasc. Biol. 16:1996;19-27.
13. Gerritse K., Laman J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J., Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 93:1996;2499-2504.
14. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S., Vitek M.P., Gajdusek D.C. Interleukin-1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7606-7610.
15. Grewal I.S., Flavell R.A. The CD40 ligand: at the center of the immune universe? Immunol. Res. 16:1997;59-70.
16. Kalaria R.N. Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease. Ann. NY Acad. Sci. 826:1997;263-271.
17. Kalaria R.N., Harshbarger-Kelly M., Cohen D.L., Premkumar D.R. Molecular aspects of inflammatory and immune responses in Alzheimer's disease. Neurobiol. Aging. 17:1996;687-693.
18. Kalaria R.N., Hedera P. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. NeuroReport. 6:1995;477-480.
19. Laman J.D., de Smet B.J., Schoneveld A., van Meurs M. CD40-CD40L interactions in atherosclerosis. Immunol. Today. 18:1997;272-277.
20. Libby P., Sukhova G., Lee R.T., Galis Z.S. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J. Cardiovasc. Pharmacol. 25(2):1995;S9-S12. Suppl.
21. Luscher T.F., Wenzel R.R. Endothelin and endothelin antagonists: pharmacology and clinical implications. Agents Actions. 45:1995;237-253. Suppl.
22. Maat-Schieman M.L., van Duinen S.G., Rozemuller A.J., Haan J., Roos R.A. Association of vascular amyloid beta and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;273-284.
23. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 96:1997;396-399.
24. Mattson M.P., Barger S.W., Furukawa K., Bruce A.J., Wyss-Coray T., Mark R.J., Mucke L. Cellular signalling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res. Brain Res. Rev. 23:1997;47-61.
25. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21:1995;195-218.
26. Miller A., Lanir N., Shapiro S., Revel M., Honigman S., Kinarty A., Lahat N. Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases. J. Neuroimmunol. 64:1996;151-161.
27. Noelle R.J., Mackey M., Foy T., Buhlmann J., Burns C. CD40 and its ligand in autoimmunity. Ann. NY Acad. Sci. 815:1997;384-391.
28. Pan W., Banks W.A., Kastin A.J. Permeability of the blood-brain and blood-spinal cord barriers to interferons. J. Neuroimmunol. 76:1997;105-111.
29. Parry S.L., Hasbold J., Holman M., Klaus G.G. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by co-stimulation with IL-4 and anti-CD40. J. Immunol. 152:1994;2821-2829.
30. Raitano A.B., Korc M. Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line. J. Biol. Chem. 265:1990;10466-10472.
31. Saija A., Princi P., Lanza M., Scalese M., Aramnejad E., De Sarro A. Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci. 56:1995;775-784.
32. Schonbeck U., Mach F., Sukhova G.K., Murphy C., Bonnefoy J.Y., Fabunmi R.P., Libby P. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signalling in plaque rupture? Circ. Res. 81:1997;448-454.
33. Shalit F., Sredni B., Stern L., Kott E., Huberman M. Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients. Neurosci. Lett. 174:1994;130-132.
34. Singh V.K. Studies of neuroimmune markers in Alzheimer's disease. Mol. Neurobiol. 9:1994;73-81.
35. 1-42 induced endothelial toxicity. Brain Res. 762:1997;144-152.
36. M. Tewari, V.M. Dixit, Signalling through members of the tumor necrosis factor receptor family, in: C.H. Heldin, M. Purton (Eds.), Signal Transduction, Chapman & Hall, London, 1996, pp. 79-92.
37. Vandenabeele P., Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? Immunol. Today. 12:1991;217-219.
38. Verbeek M.M., de Waal R.M., Schipper J.J., van Nostrand W.E. Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J. Neurochem. 68:1997;1135-1141.
39. Webster S., Bonnell B., Rogers J. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide. Am. J. Pathol. 150:1997;1531-1536.
40. Webster S., Lue L.F., Brachova L., Tenner A.J., McGeer P.L., Terai K., Walker D.G., Bradt B., Cooper N.R., Rogers J. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol. Aging. 18:1997;415-421.
41. Wewetzer K., Heiniger C., Seilheimer B. An improved cell-ELISA for the differential screening of antibodies against cell surface molecules of viable adherent Schwann cells. J. Immunol. Methods. 191:1996;171-178.
42. Yamada M., Itoh Y., Shintaku M., Kawamura J., Jensson O., Thorsteinsson L., Suematsu N., Matsushita M., Otomo E. Immune reactions associated with cerebral amyloid angiopathy. Stroke. 27:1996;1155-1162.
43. Zarow C., Barron E., Chui H.C., Perlmutter L.S. Vascular basement membrane pathology and Alzheimer's disease. Ann. NY Acad. Sci. 826:1997;147-160.